Confirm the product, indication and renal measure. The selected summary is not a complete prescribing monograph.
Choose a source to read (2)
Display order is not a clinical ranking. Date of retrieval is not the label revision date. Sources are never merged into one regimen. Other sources and conflicts remain below.
Official source
DailyMed / TPOXX exact oral and injection label
Product / population
TPOXX oral capsules for labeled human smallpox treatment; the oral weight-based schedule starts at 13 kg. This is not an mpox efficacy or eligibility recommendation.
Renal measure
CrCl and ESRD/hemodialysis; oral-formulation statement
Selected sections only. Source mirror and underlying label are not independent confirmations.
Renal dosing, restrictions and evidence limits
The official capsule section requires no adjustment across renal impairment, including ESRD with hemodialysis. Use the separate labeled oral weight regimen; this renal finding does not authorize IV treatment in severe impairment or establish a supplemental dialysis dose.
Source revision: 4/2024 | Retrieved: 2026-09-09. Retrieval date is not the revision date.
All sources, comparison tools and evidence navigation
Source-first renal review
Evidence sources and renal implications
Choose a source to jump directly to its locally stored result. Qualitative precautions and evidence gaps remain visible even when no numerical clearance schedule is supplied.
Qualified no-adjustment statement. Apply only to the population, product and renal range described in this source.
TPOXX oral capsules for labeled human smallpox treatment; the oral weight-based schedule starts at 13 kg. This is not an mpox efficacy or eligibility recommendation.
Renal method: CrCl and ESRD/hemodialysis; oral-formulation statement Retrieved: 2026-09-09
Qualified no-adjustment statement. Apply only to the population, product and renal range described in this source.
TPOXX oral capsules for labeled human smallpox treatment; the oral weight-based schedule starts at 13 kg. This is not an mpox efficacy or eligibility recommendation.
Renal method: CrCl and ESRD/hemodialysis; oral-formulation statement Retrieved: 2026-09-09
Locate a word or phrase within this drug's source summaries. Choose all sources or one source to focus the search. The selection never hides warnings or source text, changes a dose, or proves that a renal finding is absent.
Find:
Enter at least two characters. Searches stay on this page and are not saved or sent.
All source summaries, original wording and provenance
Before applying a renal protocol
Check the setting. Compare whole sources.
No patient-specific dose is calculated. Context choices only display reminders; they do not validate, hide or change any regimen.
Share a reproducible source review
Choose sources below, then open a print-ready comparison with product scope, renal method, dates and cautions. Links can pin the exact local cards; they never contain patient values or choose a dose.
Select two distinct source versions. The complete stored summaries will appear below.
Source-by-source comparison
These protocols may disagree and may apply to different settings. This view does not reconcile or endorse a patient-specific regimen.
Build a source-review outline for documentation
This creates a blank decision outline with the source identities you select, not a dose recommendation or completed clinical assessment. No patient fields are collected, saved or sent. Complete the clinical decisions in your approved documentation system.
Choose one or two sources above or use the source checkboxes below.
Renal-context checklist: population, kidney trend and dialysis
These prompts are a reading aid, not a prescription checklist or proof that all requirements have been met. No selections are stored or sent to a server.
Read the exact source scope, renal metric and date before selecting a row. No applicability assessment has been performed.
These are specific issues found during source review, not an automated judgment that one source is universally correct. A label mirror and its original label are not independent evidence.
route and excipient
Oral renal permission is not IV eligibility
The capsule and injection renal statements are different because the injection has an additional excipient-related restriction.
How to use this: Confirm route and labeled indication before applying the source.
Choose a source, then jump to its renal or dialysis section. These links locate stored text; they do not merge regimens or certify that sources agree.
New source summary - independent clinical review pending. Summaries of the identified label sections are included locally. Source import and numeric transcription checks are not independent two-reference validation. Do not treat this card as an approved institutional dosing protocol.
Official source
DailyMed / TPOXX exact oral and injection label
TPOXX oral capsules for labeled human smallpox treatment; the oral weight-based schedule starts at 13 kg. This is not an mpox efficacy or eligibility recommendation.
Method: CrCl and ESRD/hemodialysis; oral-formulation statement
TPOXX oral capsules for labeled human smallpox treatment; the oral weight-based schedule starts at 13 kg. This is not an mpox efficacy or eligibility recommendation.
Method: CrCl and ESRD/hemodialysis; oral-formulation statement
No dialysis or renal heading shown? Read the complete source summary. Absence of a heading is not evidence that dose adjustment is unnecessary.
Compare or copy source versions
All content below is stored locally. Read a whole source version; do not combine its dose with another source's interval, renal metric or dialysis assumptions.
Exact product and population matter. This added page contains locally stored, source-specific clinical summaries. Historical handbook information, when present, is identified separately and may conflict with U.S. labeling. Confirm indication, population, kidney-function method, monitoring and the full prescribing information before applying a regimen.
TPOXX oral capsules for labeled human smallpox treatment; the oral weight-based schedule starts at 13 kg. This is not an mpox efficacy or eligibility recommendation.
RDM54-SCOPE-tecovirimat-tpoxx-oral · Source section: Selected source product scopeRenal section finder
DailyMed / SIGA Technologies, Inc. · TPOXX oral capsules for labeled human smallpox treatment; the oral weight-based schedule starts at 13 kg. This is not an mpox efficacy or eligibility recommendation.
Qualified no-adjustment statement. Apply only to the population, product and renal range described in this source.
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Renal dosing, restrictions and evidence limits
The official capsule section requires no adjustment across renal impairment, including ESRD with hemodialysis. Use the separate labeled oral weight regimen; this renal finding does not authorize IV treatment in severe impairment or establish a supplemental dialysis dose.
GlobalRPh-hosted RX List · TPOXX oral capsules for labeled human smallpox treatment; the oral weight-based schedule starts at 13 kg. This is not an mpox efficacy or eligibility recommendation.
Renal method: CrCl and ESRD/hemodialysis; oral-formulation statement Source date: Source revision date not established in selected retrieval. Retrieved: 2026-09-09
Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Qualified no-adjustment statement. Apply only to the population, product and renal range described in this source.
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Renal dosing, restrictions and evidence limits
The capsule renal statement requires no adjustment for mild, moderate or severe impairment, including ESRD requiring hemodialysis. This permission belongs to the oral formulation, not TPOXX injection. The selected paragraph does not provide a dialysis replacement dose.
RDM54-rxlist-tecovirimat-tpoxx-oral-3c7be644e4-C1 · Source locator: Dosage and Administration; Renal Impairment; selected Warnings and Precautions
Source-specific limits
Selected sections only. Source mirror and underlying label are not independent confirmations.
Additional summaries stored on this page: 1 official-label, 1 RX List, 0 professional, 0 handbook. Empty additional-source groups are not shown. A missing layer is not a no-adjustment recommendation.
Source-section locators identify where retained content came from. A source-section identifier does not assert that every numeric statement has been independently corroborated. The local text hash is not a hash of original HTML, an FDA PDF or SPL XML.
This page is an additional exact-product entry, not a recovered GlobalRPh monograph. Its primary scope text and separately attributed clinical summaries are locally included.